FTSE All-Share
|
4 922,46
|
-34,72
|
-0,70 %
|
Analysen zu FTSE All-Share-Werten
| 09.01.24 | GSK Equal Weight | Barclays Capital | |
| 09.01.24 | GSK Sell | UBS AG | |
| 09.01.24 | Rio Tinto Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.01.24 | Shell Overweight | JP Morgan Chase & Co. | |
| 08.01.24 | Diageo Outperform | Bernstein Research | |
| 08.01.24 | Shell Outperform | RBC Capital Markets | |
| 08.01.24 | Rio Tinto Neutral | UBS AG | |
| 08.01.24 | Shell Buy | Jefferies & Company Inc. | |
| 08.01.24 | Shell Overweight | Barclays Capital | |
| 08.01.24 | Shell Buy | UBS AG | |
| 08.01.24 | HSBC Holdings Buy | Jefferies & Company Inc. | |
| 05.01.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 05.01.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 04.01.24 | BP Overweight | Barclays Capital | |
| 04.01.24 | Shell Overweight | Barclays Capital | |
| 04.01.24 | BP Outperform | RBC Capital Markets | |
| 04.01.24 | Shell Outperform | RBC Capital Markets | |
| 03.01.24 | Unilever Underweight | JP Morgan Chase & Co. | |
| 03.01.24 | AstraZeneca Overweight | Barclays Capital | |
| 03.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.01.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 03.01.24 | GSK Buy | Jefferies & Company Inc. | |
| 02.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.12.23 | Unilever Market-Perform | Bernstein Research | |
| 27.12.23 | GSK Equal Weight | Barclays Capital | |
| 27.12.23 | AstraZeneca Buy | UBS AG | |
| 22.12.23 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 20.12.23 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 20.12.23 | Diageo Outperform | Bernstein Research | |
| 20.12.23 | Vodafone Group Equal Weight | Barclays Capital | |
| 20.12.23 | HSBC Holdings Sector Perform | RBC Capital Markets | |
| 19.12.23 | Rio Tinto Neutral | UBS AG | |
| 19.12.23 | Vodafone Group Buy | Deutsche Bank AG | |
| 19.12.23 | GSK Buy | Deutsche Bank AG | |
| 18.12.23 | Vodafone Group Equal Weight | Barclays Capital | |
| 18.12.23 | Unilever Market-Perform | Bernstein Research | |
| 15.12.23 | AstraZeneca Hold | Deutsche Bank AG | |
| 15.12.23 | GSK Buy | Deutsche Bank AG | |
| 15.12.23 | Unilever Underperform | Jefferies & Company Inc. | |
| 14.12.23 | National Grid Overweight | JP Morgan Chase & Co. |
HOT STOCKS DER LETZTEN 3 TAGE
| AstraZeneca | 6 |
| Rio Tinto | 6 |
| GSK | 5 |
| HSBC Holdings | 5 |
| Glencore | 4 |
| Unilever | 3 |
| Shell | 2 |
| London Stock Exchange | 2 |
| BAT | 1 |
| Vodafone Group | 1 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.